Physician profile
Douglas J Fox
NPI 1427044924
$947,739.62
in general payments reported to CMS, 2019-2025
5 companies · $106K in 2025
The $106K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $9,988 · 2021: $196K · 2022: $19K · 2023: $290K · 2024: $293K · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $600K · Consulting Fee: $69K · Travel and Lodging: $19K · Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $600,000.00 |
| Consulting Fee | $69,375.00 |
| Travel and Lodging | $19,287.99 |
| Food and Beverage | $1,282.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $901,707.25 | 2021-2025 | Mazor X System, Midas Rex, Unid_pass |
| Medtronic USA, INC. | $43,189.88 | 2019-2020 | |
| Alphatec Spine, INC | $2,782.83 | 2024 | Other - Miscellaneous, Invictus Open, Battalion Tlif - PC |
| Abbott Laboratories | $43.52 | 2023 | Proclaim |
| Providence Medical Technology, INC. | $16.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.